<!DOCTYPE html>
<html lang="en">
    <head>
        <meta charset="utf-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge">
        <meta name="viewport" content="width=device-width, initial-scale=1">

        <meta content="Mustafaoglu Lab" name="Mustafaoglu Lab @ Sabanci University">
        <meta content="Nur Mustafaoglu, Sabanci University" name="keywords">
        <meta content="Copyright (c) 2020 Onur Varol" name="Copyright">
        <meta content="text/html; charset=utf-8" http-equiv="Content-Type">
        <meta property="og:title" content="Mustafaoglu Lab @ Sabanci University">
        <meta property="og:type" content="website">
        <meta property="og:url" content="http://mustafaoglulab.com/">
        <meta property="og:image" content="http://mustafaoglulab.com/img/mustafaoglu-lab-logo.png">
        <meta property="og:image:type" content="image/png">
        <meta property="og:image:width" content="400">
        <meta property="og:image:height" content="400">
        <meta property="og:description" content="This site contains information about Mustafaoglu Lab.">
        <link id="page_favicon" href="img/favicon.ico" rel="icon" type="image/x-icon" />
        
        <link rel="stylesheet" href="css/bootstrap.min.css">
        <script src="js/jquery.min.js"></script>
        <script src="js/popper.min.js"></script>
        <script src="js/bootstrap.min.js"></script>

        <link type="text/css" rel="stylesheet" href="css/custom.css" />
        <link type="text/css" rel="stylesheet" href="css/hover-min.css" />

        <title>Mustafaoglu Lab Website</title>

        <script type="text/javascript">
            $(document).ready(function () {
                $('[data-toggle="tooltip"]').tooltip(); 
                $('#header-container').load('template_header.html');
                $('#footer-container').load('template_footer.html');
            });
        </script>

    </head>

    <body>
        <div id="header-container"></div>
        <div class="jumbotron" style="background-image: url(img/brains-banner-4.png);"></div>

        <div class="container">
            
            <div class="row">
                <h3>Blood-brain barrier</h3>
            </div>
            <div class="row">
                <div class="col-md-4">
                    <img class="img-responsive" alt="Blood brain barrier" src="img/research/BBB-Schematic.png">
                    <br>
                    <img class="img-responsive" alt="Blood brain barrier chip" src="img/research/BBB-on-chip-illustration-researchImage-2.png">
                    <br>
                    <img class="img-responsive" alt="Blood brain barrier chip" src="img/research/BBB-chip-staining.png">
                    <br>
                </div>
                <div class="col-md-8">
                    Blood-brain barrier (BBB) acts as a highly selective physiological and chemical gate for protecting the brain from pathogens and toxins in a healthy human body. Under disease conditions, however, it becomes an obstacle that needs to be overcome for delivering the drugs since many small molecules (>400 Da), large biologics and proteins can not cross the BBB. More than 99% of the therapeutic agents falls into this population of drugs that cannot cross the BBB thus making the systemic delivery of drugs for CNS treatment extremely challenging. There is a great need of a model that mimicks the <i>in vivo</i> conditions and function of the BBB to be able to screen therapeutics that are enable to cross the BBB. Therefore, the <b>objective</b> of this project is to model a physiologically relevant <i>in vitro</i> BBB models utilizing Organ Chip technology to study transport mechanisms on the BBB and develop transcytosis assays for drug development. This project involves several sub-aims and branches to reach the ultimate goal of modeling healthy and disease models of the BBB, and develop shuttling agents for treatment of central nervous system (CNS) diseases.

                    <ul> 
                        <li> Developing microfluidic <i>in vitro</i> human BBB Chip model with blood flow</li>
                        <li> Characterization of iPS-derived brain microvascular endothelial cells comparing their morphology, biomarker expression, and function to <i>in vivo</i> conditions</li>
                        <li> Developing antibody transcytosis assays on the BBB Chip for screening of the antibodies targeting a brain specific receptor</li>
                        <li> Studying peptides and small molecules that are opening the BBB reversibly for drug delivery purposes</li>
                        <li> Investigating the effects of the microbiome changes in the intestine to the BBB integrity </li>
                        <li> Developing BBB-Alzhimer Disease Chip model</li>
                        <li> Developing ischemic perfusion model on the BBB Chips</li>
                    </ul>
                    <br/>

                    <b>Podcast (Turkish) </b>
                    <a href="https://anchor.fm/cortado" target="_blank"> Cortado </a>
                    <iframe src="https://anchor.fm/cortado/embed/episodes/38--Salk-Neden-her-ila-beyne-giremez-edik5b/a-a1pvrs" width="100%" frameborder="0" scrolling="no"></iframe>

                    <b>Publications:</b>
                    <ul>
                        <li><p>Tae-Eun Park*, <b>Nur Mustafaoglu*</b>, Anna Herland, Ryan Hasselkus, Robert Mannix, Edward A. FitzGerald, Rachelle Prantil-Baun, Alexander Watters, Olivier Henry, Maximilian Benz, Henry Sanchez, Heather McCrea, Liliana Christova Goumnerova, Hannah W. Song, Sean P. Palecek, Eric Shusta, and Donald E. Ingber (2019). <a href="https://www.nature.com/articles/s41467-019-10588-0" target="_blank">Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies.</a> <i>Nature Communications</i>, 10, 2621.</p>
                            <ul><span style="color:red;">Media Coverages:</span>         
                                <li>Enhanced human Blood-Brain Barrier Chip performs in vivo-like drug and antibody transport: 
                                                <a href="https://wyss.harvard.edu/enhanced-human-blood-brain-barrier-chip-performs-in-vivo-like-drug-and-antibody-transport/" target="_blank"> Wyss Institute</a>,
                                                <a href="hhttps://www.rdmag.com/news/2019/06/enhanced-human-blood-brain-barrier-chip-performs-vivo-drug-and-antibody-transport" target="_blank"> R&#38D</a>,
                                                <a href="https://www.longroom.com/discussion/1522881/enhanced-human-blood-brain-barrier-chip-performs-in-vivo-like-drug-and-antibody-transport" target="_blank"> Long Room</a>,
                                                <a href="https://www.drugdiscoverytrends.com/enhanced-human-blood-brain-barrier-chip-performs-in-vivo-like-drug-and-antibody-transport/" target="_blank"> Drug Discovery and Development</a>,
                                                <a href="https://www.sciencedaily.com/releases/2019/06/190613143516.htm" target="_blank"> Science Daily</a>,
                                                <a href="https://www.eurekalert.org/pub_releases/2019-06/wifb-ehb061119.php" target="_blank"> EurekAlert!</a>,
                                                <a href="https://phys.org/news/2019-06-human-blood-brain-barrier-chip-vivo-like.html" target="_blank"> Phys.org</a>,
                                </li>
                                <li>An Enhanced Human Blood-Brain Barrier Chip for Drug Discovery: <a href="https://www.technologynetworks.com/drug-discovery/news/human-blood-brain-barrier-chip-aids-development-of-brain-targeting-drugs-320624">Technology Networks</a></li>
                                <li>New Microfluidic Chip to Accurately Model Blood-Brain Barrier: <a href="https://www.medgadget.com/2019/06/new-microfluidic-chip-to-accurately-model-blood-brain-barrier.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+Medgadget+%28Medgadget%29">Medgadget</a></li>
                                <li>Chip Device Simulates Blood-Brain Barrier: <a href="https://sciencebusiness.technewslit.com/?p=36826">Science and Enterprise</a></li>
                                            <br/>

                            </ul>
                        
                        <li><p>Golnaz Morad, Christopher V. Carman, Elliott J. Hagedorn, Julie R. Perlin, Leonard I. Zon, <b>Nur Mustafaoglu</b>, Tae-Eun Park, Donald E. Ingber, Cassandra C. Daisy, and Marsha A. Moses (2019). <a href="https://pubs.acs.org/doi/10.1021/acsnano.9b04397" target="_blank">Tumor-derived extracellular vesicles breach the intact blood brain barrier via transcytosis.</a> <i>ACS Nano</i>, in print.</p>
                                        
                            <ul><span style="color:red;">Media Coverages:</span> 
                                <li>Sneaky Spread: <a href="http://ct.moreover.com/?a=40178414056&p=1pl&v=1&x=UItwDofXPHYOGTDF7Dw5fw" target="_blank">Medical health News</a></li>
                                <li>Study reveals how breast cancer uses exosomes to metastasize to the brain: <a href="https://www.news-medical.net/news/20190913/Study-reveals-how-breast-cancer-uses-exosomes-to-metastasize-to-the-brain.aspx">News Medical Life Sciences</a></li>
                                <li>How breast cancer uses exosomes to metastasize to the brain: <a href="https://www.longroom.com/discussion/1626045/how-breast-cancer-uses-exosomes-to-metastasize-to-the-brain">Long Room News</a></li>
                                <li>Study details how exosomes, released by the breast tumor, tricks cells in the blood-brain barrier into taking them up: <a href="https://medicalxpress.com/news/2019-09-exosomes-breast-tumor-cells-blood-brain.html">MedicalXpress</a></li>
                                <li>How breast cancer uses exosomes to metastasize to the brain: <a href="https://www.sciencedaily.com/releases/2019/09/190912153454.htm">Science Daily</a></li>
                                <br/>
                            </ul>
                                <br/>
                        </li>
                    </ul>       
                </div>        
            </div>


            <div class="row"><h3>Site-specific functionalization of antibodies and Fab fragments for enhanced diagnostic applications</h3></div>
            <div class="row">
                <div class="col-md-12">
                    <b>Objective:</b> Immobilization of antibodies and their Fab fragments in an oriented manner to small scalled diagnostic surfaces such as microfluidic devices and nanoparticles while preserving their antigen binding activity and structure stability.</br>

                    <b>Publications:</b> </br>
                    <ul>
                        <li><p><b>Nur Mustafaoglu</b>, Tanyel Kiziltepe, Basar Bilgicer (2017). <a href="http://pubs.rsc.org/en/content/articlelanding/2017/nr/c7nr03096g#!divAbstract" target="_blank">Site-specific conjugation of antibody on gold nanoparticle surface for one-step diagnosis of prostate specific antigen with dynamic light scattering.</a> <i>Nanoscale</i>, in print.<br/>
                        <span style="color:red;">Media Coverage:</span> Notre Dame Research: <a href="https://research.nd.edu/news/developing-the-gold-standard-for-efficient-diagnostics/" target="_blank">Developing the gold standard for efficient diagnostics.</a> <br/></p></li>

                        <li><p><b>Nur Mustafaoglu</b>, Nathan J. Alves, Basar Bilgicer (2015). <a href="http://pubs.acs.org/doi/abs/10.1021/acs.langmuir.5b01734" target="_blank">Oriented immobilization of Fab fragments by site-specific biotinylation at the conserved Nucleotide Binding Site for enhanced antigen detection.</a> <i>Langmuir</i>, 31(35), 9728-9736.<br/></p></li>

                        <li><b>Nur Mustafaoglu</b>, Nathan J. Alves, Basar Bilgicer (2015). <a href="http://onlinelibrary.wiley.com/doi/10.1002/bit.25558/abstract" target="_blank">Site-specific fab fragment biotinylation at the conserved nucleotide binding site for enhanced Ebola detection.</a> <i>Biotechnology and Bioengineering</i>, 112(7), 1327-1334.<br/></p>
                        <iframe width="560" height="315" src="https://www.youtube.com/embed/7BSRV6fxedA" frameborder="0" allowfullscreen></iframe></li>

                        <li><p>Nathan J. Alves,  <b>Nur Mustafaoglu</b>, Basar Bilgicer (2014). <a href="http://pubs.acs.org/doi/abs/10.1021/bc500211d" target="_blank">Conjugation of a Reactive Thiol at the Nucleotide Binding Site (NBS) for Site-Specific Antibody Functionalization.</a> <i>Bioconjugate Chemistry</i>, 25(7), 1198-1202.<br/></p> </li>
                                        
                        <li><p>Nathan J. Alves, <b>Nur Mustafaoglu</b>, Basar Bilgicer (2013). <a href="http://dx.doi.org/10.1016/j.bios.2013.05.052" target="_blank">Oriented antibody immobilization by site-specific UV photocrosslinking of biotin at the conserved nucleotide binding site for enhanced antigen detection.</a> <i>Biosensors and Bioelectronics</i>, 49, 387–393.<br/></p></li>
                    </ul>
                </div>
            </div>

            <div class="row">
                <h3>Antibody purification</h3>
            </div>
            <div class="row">
                <div class="col-md-4">
                    <img class="img-responsive" alt="antibody purification" src="img/research/antibody-purification-2.png"> 
                </div>

                <div class="col-md-8">
                    The <b>objective</b> of this project is to design a novel affinity chromatography techniques for purification of monoclonal and polyclonal antibodies from cell culture media and ascites fluids. This method utilizes the nucleotide-binding site (NBS) that is located on variable domain of Fab region nearly all antibodies to facilitate capturing antibodies on a membrane affinity column.</br>
                    
                    <b>Publications:</b>
                        <ul>
                            <li><p><b>Nur Mustafaoglu</b>, Tanyel Kiziltepe, Basar Bilgicer (2016). <a href="http://pubs.rsc.org/en/Content/ArticleLanding/2016/AN/C6AN02145J" target="_blank">Antibody purification via affinity membrane chromatography method utilizing nucleotide binding site targeting with a small molecule.</a> <i>Analyst</i>, 141, 6571-6582.<br/></p></li>
                        </ul>
                </div>
            </div>

        </div>
        <br>
        <div id="footer-container"></div>
    </body>

</html>